NEUROENDOCRINOLOGY is a prestigious interdisciplinary journal published by KARGER, serving the vibrant fields of cellular and molecular neuroscience, endocrine systems, and metabolism. With an ISSN of 0028-3835 and an E-ISSN of 1423-0194, this journal stands at the forefront of neuroendocrinology research, boasting an impactful position in the academic community, as highlighted by its 2023 Scopus rankings placing it in the top quartiles across multiple relevant categories. Since its inception in 1965, NEUROENDOCRINOLOGY has consistently contributed to the advancement of knowledge and understanding in the interplay between the nervous system and endocrine functions. Although it does not currently offer Open Access, the journal aims to disseminate groundbreaking studies, reviews, and clinical insights that address critical issues in neuroendocrine interactions. With its headquarters in Basel, Switzerland, NEUROENDOCRINOLOGY remains a vital resource for researchers, professionals, and students eager to explore the complexities of neuroendocrine dynamics and their implications for health and disease.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Islets is a vital academic journal dedicated to advancing our understanding of the complex mechanisms underlying islet biology and its implications in health and disease. Published by Taylor & Francis Inc, this journal aims to serve as a premier platform for researchers, clinicians, and students engaged in the fields of Endocrinology, Diabetes, and Metabolism. With a focus on publishing high-quality research articles, reviews, and clinical studies, Islets seeks to contribute significantly to the ongoing dialogue in these critical areas of biomedical research. Boasting a Category Quartile of Q3 in both Endocrinology and Endocrinology, Diabetes and Metabolism, as well as relevant Scopus rankings that underscore its role in the research community, Islets provides an essential resource for those looking to stay informed and make impactful contributions to the field. While offering exclusive insights from 2009 to 2024, the journal encourages an open exchange of ideas that paves the way for future discoveries and advancements in islet research.

Expert Review of Endocrinology & Metabolism is a premier journal dedicated to advancing the field of endocrinology and metabolism, published by Routledge Journals, Taylor & Francis Ltd, in the United Kingdom. With a robust focus on the latest research, innovative treatments, and clinical practices, this journal serves as an essential resource for healthcare professionals, researchers, and students seeking to stay abreast of developments in diabetes, obesity, thyroid disorders, and other endocrine-related conditions. Achieving a commendable Q2 status in Endocrinology, Diabetes, and Metabolism in the 2023 ranking, Expert Review of Endocrinology & Metabolism holds strong standing with an impressive Scopus rank, placing it at the 53rd percentile among its peers. The journal embraces a comprehensive approach, offering critical reviews, original research articles, and insights on emerging trends and technologies in the field. Although not an open-access journal, it provides extensive access options for subscribers and institutions, encouraging ease of dissemination and academic engagement. Through its commitment to high-quality content, Expert Review of Endocrinology & Metabolism remains pivotal for professionals aiming to enhance their understanding and practice in this vital area of medicine.

PANCREAS, published by Lippincott Williams & Wilkins, is a preeminent journal dedicated to advancing the field of endocrinology, diabetes, hepatology, and internal medicine. With an ISSN of 0885-3177 and E-ISSN of 1536-4828, this journal aims to disseminate high-quality research findings and clinical insights that are pivotal for professionals in these areas. The journal has established itself with an impressive Q2 ranking across multiple categories in the 2023 rankings, including endocrinology, diabetes and metabolism, hepatology, and internal medicine. Although it offers no open access options, the content is meticulously curated to enrich the knowledge base of researchers and practitioners. The Scopus rankings further underscore its influence, ranking #64 in Internal Medicine and #36 in Hepatology, reflecting its commitment to scholarly excellence. Based in the United States at Two Commerce Square, 2001 Market St, Philadelphia, PA 19103, PANCREAS serves as a central hub for innovative research from 1986 to 2024, making it an essential resource for those engaged in these rapidly evolving fields.

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.